Bioelectronic medicine maker Tivic Health's Q3 net loss widens-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Bioelectronic medicine maker Tivic Health's Q3 net loss widens

Reuters11-15

Bioelectronic medicine maker <a href="https://laohu8.com/S/TIVC">Tivic Health</a>'s Q3 net loss widens

Overview

Tivic Health Q3 revenue rises to $146,000, final quarter for direct ClearUP sales
Net loss widens to $2.6 mln in Q3, impacted by consumer business wind down

Outlook

Company did not provide specific financial guidance for future quarters or years

Result Drivers

MILITARY INTEREST - Tivic advanced discussions on deploying Entolimod as a military countermeasure at MHSRS
Operating expenses totaled $2.3 million, compared with $1.5 million for the same period in 2024.

Key Details

Metric	Beat/Miss	Actual	Consensus Estimate
Q3 Revenue		$146,000
Q3 Net Income		-$2.60 mln
Q3 Basic EPS		-$1.97
Q3 Gross Profit		-$145,000
Q3 Operating Expenses		$2.34 mln
Q3 Operating Income		-$2.48 mln

Press Release: ID:nACSKJPQDa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

empty

No comments yet

Most Discussed

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2583828426?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-15 05:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583828426","market":"nz","top_or_hot":-1,"title":"Bioelectronic medicine maker Tivic Health's Q3 net loss widens","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Bioelectronic medicine maker <a href=\"https://laohu8.com/S/TIVC\">Tivic Health</a>'s Q3 net loss widens</title></head><body><p><span>Overview</span></p><ul><li><p>Tivic Health Q3 revenue rises to $146,000, final quarter for direct ClearUP sales</p></li><li><p>Net loss widens to $2.6 mln in Q3, impacted by consumer business wind down</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company did not provide specific financial guidance for future quarters or years</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>MILITARY INTEREST - Tivic advanced discussions on deploying Entolimod as a military countermeasure at MHSRS</p></li><li><p>Operating expenses totaled $2.3 million, compared with $1.5 million for the same period in 2024. </p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Revenue</p></td><td></td><td><p>$146,000</p></td><td></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>-$2.60 mln</p></td><td></td></tr><tr><td><p>Q3 Basic EPS</p></td><td></td><td><p>-$1.97</p></td><td></td></tr><tr><td><p>Q3 Gross Profit</p></td><td></td><td><p>-$145,000</p></td><td></td></tr><tr><td><p>Q3 Operating Expenses</p></td><td></td><td><p>$2.34 mln</p></td><td></td></tr><tr><td><p>Q3 Operating Income</p></td><td></td><td><p>-$2.48 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nACSKJPQDa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bioelectronic medicine maker Tivic Health's Q3 net loss widens</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioelectronic medicine maker Tivic Health's Q3 net loss widens\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-15 05:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>Bioelectronic medicine maker <a href=\"https://laohu8.com/S/TIVC\">Tivic Health</a>'s Q3 net loss widens</title></head><body><p><span>Overview</span></p><ul><li><p>Tivic Health Q3 revenue rises to $146,000, final quarter for direct ClearUP sales</p></li><li><p>Net loss widens to $2.6 mln in Q3, impacted by consumer business wind down</p></li></ul><p><span>Outlook</span></p><ul><li><p>Company did not provide specific financial guidance for future quarters or years</p></li></ul><p><span>Result Drivers</span></p><ul><li><p>MILITARY INTEREST - Tivic advanced discussions on deploying Entolimod as a military countermeasure at MHSRS</p></li><li><p>Operating expenses totaled $2.3 million, compared with $1.5 million for the same period in 2024. </p></li></ul><p><span>Key Details</span></p><table><tbody><tr><td><p><span>Metric</span></p></td><td><p><span>Beat/Miss</span></p></td><td><p><span>Actual</span></p></td><td><p><span>Consensus Estimate</span></p></td></tr><tr><td><p>Q3 Revenue</p></td><td></td><td><p>$146,000</p></td><td></td></tr><tr><td><p>Q3 Net Income</p></td><td></td><td><p>-$2.60 mln</p></td><td></td></tr><tr><td><p>Q3 Basic EPS</p></td><td></td><td><p>-$1.97</p></td><td></td></tr><tr><td><p>Q3 Gross Profit</p></td><td></td><td><p>-$145,000</p></td><td></td></tr><tr><td><p>Q3 Operating Expenses</p></td><td></td><td><p>$2.34 mln</p></td><td></td></tr><tr><td><p>Q3 Operating Income</p></td><td></td><td><p>-$2.48 mln</p></td><td></td></tr></tbody></table><p>Press Release: <span>ID:nACSKJPQDa</span></p><p>For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.</p><p>(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nL1N3WQ14X:1","article_id":"2583828426","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583828426","pubTimestamp":1763156387,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Bioelectronic medicine maker Tivic Health's Q3 net loss widensOverviewTivic Health Q3 revenue rises to $146,000, final quarter for direct ClearUP salesNet loss widens to $2.6 mln in Q3, impacted by co","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","TIVC":"Tivic Health Systems, Inc."},"translate_title":"生物电子药品制造商Tivic Health第三季度净亏损扩大","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TIVC":0.9},"content_text":"Bioelectronic medicine maker Tivic Health's Q3 net loss widensOverviewTivic Health Q3 revenue rises to $146,000, final quarter for direct ClearUP salesNet loss widens to $2.6 mln in Q3, impacted by consumer business wind downOutlookCompany did not provide specific financial guidance for future quarters or yearsResult DriversMILITARY INTEREST - Tivic advanced discussions on deploying Entolimod as a military countermeasure at MHSRSOperating expenses totaled $2.3 million, compared with $1.5 million for the same period in 2024. Key DetailsMetricBeat/MissActualConsensus EstimateQ3 Revenue$146,000Q3 Net Income-$2.60 mlnQ3 Basic EPS-$1.97Q3 Gross Profit-$145,000Q3 Operating Expenses$2.34 mlnQ3 Operating Income-$2.48 mlnPress Release: ID:nACSKJPQDaFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}